Hypertension, Vol 19, 249-254, Copyright © 1992 by American Heart Association
WM Zuo, RE Pratt, CH Heusser, JP Bews, MM de Gasparo and VJ Dzau
We have identified and characterized an anti-human renin monoclonal
antibody R1-20-5 that is selective for human active renin. R1-20-5 binds
active renin with a dissociation constant (Kd) of 2.5 x 10(-7) M/l and
inhibits renin enzymatic activity with an inhibitory constant (IC50) of 1.4
x 10(-8) M/l. R1-20-5 competes with a synthetic renin inhibitor for binding
with renin, demonstrating further that it is binding to or close to the
active site. This antibody does not bind prorenin in human plasma or
recombinant prorenin expressed by L-929 fibroblasts transfected with human
renin gene. Furthermore, trypsin activation of prorenin resulted in
immunoreactivity of the activated prorenin toward the antibody. In
addition, an immunoaffinity column of R1-20-5 coupled to Sepharose retained
active renin but had a low affinity for prorenin. A sensitive and rapid
solid phase radioimmunoassay for active renin was developed using a
"sandwich" technique employing R1-20-5 and a second non-active
site-directed monoclonal antibody to human renin. Renin levels in human
plasma samples were determined by the standard enzymatic assay, and by the
direct radioimmunoassay for active renin, before and after trypsin
activation. Trypsin treatment of plasma resulted in parallel increases in
both the plasma renin enzymatic activity and in the plasma active renin
concentration as measured by the direct radioimmunoassay. Overall, plasma
immunoreactive active renin concentration correlated significantly with
plasma renin enzymatic activity (r = 0.96, p less than 0.001). In summary,
the monoclonal antibody R1-20-5 is selective for human active renin and
should be a very useful tool for studies of the active enzyme in humans.
ARTICLES
Characterization of a monoclonal antibody specific for human active renin
Division of Cardiovascular Medicine, Stanford University School of Medicine, Calif.
This article has been cited by other articles:
![]() |
J. J. Saris, F. H. M. Derkx, R. J. A. De Bruin, D. H. W. Dekkers, J. M. J. Lamers, P. R. Saxena, M. A. D. H. Schalekamp, and A. H. Jan Danser High-affinity prorenin binding to cardiac man-6-P/IGF-II receptors precedes proteolytic activation to renin Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1706 - H1715. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Kim Measurement of the Renin-Angiotensin System in Heart Failure Biol Res Nurs, January 1, 2000; 1(3): 210 - 226. [Abstract] [PDF] |
||||
![]() |
A. H. J. Danser, C. A. M. van Kesteren, W. A. Bax, M. Tavenier, F. H. M. Derkx, P. R. Saxena, and M. A. D. H. Schalekamp Prorenin, Renin, Angiotensinogen, and Angiotensin-Converting Enzyme in Normal and Failing Human Hearts : Evidence for Renin Binding Circulation, July 1, 1997; 96(1): 220 - 226. [Abstract] [Full Text] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |